1Lai JSM,Poon ASY,Chua JKH. Efficacy and safety of the Ahmed glaucoma valve implant in Chinese eyes with complicated glaucoma[J].BrJ Opbthalmol,2000,(07):718.
2Ceballos EM,Parrish RK,Schifman JC. Outcome of Baerveldt glaucoma drainage implants for the treatment of uveitic glaucoma[J].Ophth M mology,2002,(12):2256-2260.
7YorstonD,KhawPT. A randomized trialofthe efectof 5-Fuonthe outcome of trabeculectomy in east Africa[J].British Journal of Ophthalmology,2007,(09):1028-1030.
8Chen CW,Huang HT,Bair JS. Trabeculectomy with simultaneous application of mitomycinC in refractory glauco-ma[J].Ocul Pharm,2005.175.
9Mielke C,Dawda VK,Anand N. Intraoperative 5-fluorouraeil application during primary trabeculectomy in Nigeria:a comparative study[J].Eye,2003,(07):829-834.
4Wong 1"3", Novack GD, Natarajan JV, et al. Nanomedicine for glaucoma: sus- tained release latanoprost offers a new therapeutic option with substantial benefits over eyedrops [ J ]. Drug Deliv Transl Res, 2014,4 (4) : 303 - 309.
5Garway - Heath DF, Crabb DP, Bunce C, et al. Latanoprost for open - ingle glaucoma (UKGTS) : a randomised, muhicentre, placebo - controlled :rial[J]. Lancet,2015,385 (9 975 ) : 1 295 - 1 304.
6Stein JD, Shekhawat N, Talwar N, et al. Impact of the introduction of generic latanoprost on glaucoma medication adherence [ J]. Ophthalmology, 2015, 122(4) :738 - 747.
7Jefferis JM, Taylor JP, Collerton J, et al. The association between diag- nosed glaucoma and cataract and cognitive performance in very old pen- pie: cross -sectional findings from the newcastle 85 + study[J]. Oph- thalmic Epidemiol, 2013,20 (2) : 82 - 88.
